Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 1 to 20 of 77

1.

Spectral discrimination of benign and malignant prostate tissues--a preliminary report.

Masilamani V, Rabah D, Alsalhi M, Trinka V, Vijayaraghavan P.

Photochem Photobiol. 2011 Jan-Feb;87(1):208-14. doi: 10.1111/j.1751-1097.2010.00825.x. Epub 2010 Nov 19.

PMID:
21091483
2.

A parallelism between spectral grading and Gleason grading of malignant prostate tissues.

Masilamani V, Alsalhi MS, Devanesan S, Atif M, Rabah D, Farhat K, Pu Y, Alfano RR.

Photodiagnosis Photodyn Ther. 2013 May;10(2):168-72. doi: 10.1016/j.pdpdt.2012.12.002. Epub 2013 Jan 15.

PMID:
23769283
3.

Optical biopsy of benign and malignant tissue by time resolved spectroscopy.

Masilamani V, Das BB, Secor J, AlSalhi M, Devanesan S, Prasad S, Rabah D, Alfano RR.

Technol Cancer Res Treat. 2013 Dec;12(6):559-63. doi: 10.7785/tcrt.2012.500345. Epub 2013 Jun 6.

PMID:
23745786
4.

Comparison of escalating, constant, and reduction energy output in ESWL for renal stones: multi-arm prospective randomized study.

Rabah DM, Mabrouki MS, Farhat KH, Seida MA, Arafa MA, Talic RF.

Urolithiasis. 2017 Jun;45(3):311-316. doi: 10.1007/s00240-016-0912-7. Epub 2016 Sep 29.

PMID:
27687681
5.

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.

Abusamra A, Murshid E, Kushi H, Alkhateeb S, Al-Mansour M, Saadeddin A, Rabah D, Bazarbashi S, Alotaibi M, Alghamdi A, Alghamdi K, Alsharm A, Ahmad I.

Urol Ann. 2016 Apr-Jun;8(2):123-30. doi: 10.4103/0974-7796.176872. Review.

6.

Saudi oncology society and Saudi urology association combined clinical management guidelines for prostate cancer.

Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Mahmood R, Almansour M, Murshid E, Alsharm A, Alolayan A, Ahmad I, Alkushi H, Alghamdi A, Bazarbashi S.

Urol Ann. 2014 Oct;6(4):278-85. doi: 10.4103/0974-7796.140959.

7.

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for urothelial cell carcinoma of the urinary bladder.

Alkhateeb S, Al-Mansour M, Alotaibi M, Saadeddin A, Abusamra A, Rabah D, Murshid E, Alsharm A, Ahmad I, Kushi H, Alghamdi A, Alghamdi K, Bazarbashi S.

Urol Ann. 2016 Apr-Jun;8(2):131-5. doi: 10.4103/0974-7796.176873. Review.

8.

Saudi oncology society and Saudi urology association combined clinical management guidelines for urothelial urinary bladder cancer.

Al-Mansour M, Saadeddin A, Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Murshid E, Alsharm A, Ahmad I, Alghamdi K, Bazarbashi S.

Urol Ann. 2014 Oct;6(4):273-7. doi: 10.4103/0974-7796.140941.

9.

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for testicular germ cell tumors.

Alotaibi M, Saadeddin A, Bazarbashi S, Alkhateeb S, Alghamdi A, Alghamdi K, Murshid E, Abusamra A, Rabah D, Ahmad I, Al-Mansour M, Alsharm A.

Urol Ann. 2016 Apr-Jun;8(2):141-5. doi: 10.4103/0974-7796.179240. Review.

10.

Saudi Oncology Society and Saudi Urology Association combined clinical management guidelines for renal cell carcinoma.

Alghamdi A, Alkhateeb S, Alghamdi K, Bazarbashi S, Murshid E, Alotaibi M, Abusamra A, Rabah D, Ahmad I, Al-Mansour M, Saadeddin A, Alsharm A.

Urol Ann. 2016 Apr-Jun;8(2):136-40. doi: 10.4103/0974-7796.179239. Review.

11.

Saudi oncology society and Saudi urology association combined clinical management guidelines for renal cell carcinoma.

Bazarbashi S, Alkhateeb S, Abusamra A, Rabah D, Alotaibi M, Almansour M, Murshid E, Alsharm A, Alolayan A, Ahmad I, Alghamdi K, Alghamdi A.

Urol Ann. 2014 Oct;6(4):286-9. doi: 10.4103/0974-7796.140974.

12.

Saudi oncology society and Saudi urology association combined clinical management guidelines for testicular germ cell tumors.

Alotaibi M, Bazarbashi S, Alkhateeb S, Abusamra A, Rabah D, Almansour M, Murshid E, Alsharm A, Ahmad I, Alghamdi K, Saadeddin A, Alghamdi A.

Urol Ann. 2014 Oct;6(4):290-5. doi: 10.4103/0974-7796.140978.

13.

Study of quality of life and its determinants in patients after urinary stone fragmentation.

Arafa MA, Rabah DM.

Health Qual Life Outcomes. 2010 Oct 19;8:119. doi: 10.1186/1477-7525-8-119.

14.

Validation of an Arabic ADAM questionnaire for androgen deficiency screening in the Arab community.

Rabah DM, Arafa MA.

Aging Male. 2009 Dec;12(4):95-9. doi: 10.3109/13685530903265065.

PMID:
19909202
15.

Clinical assessment and validation of an Arabic Aging Male Symptoms questionnaire in patients with androgen deficiency.

Rabah DM, Altaweel W, Arafa MA.

Aging Male. 2011 Mar;14(1):33-6. doi: 10.3109/13685538.2010.512373. Epub 2010 Sep 9.

PMID:
20828246
16.

Saudi Oncology Society clinical management guidelines for prostate cancer.

Abusamra AJ, Bazarbashi S, Bahader Y, Kushi H, Rabah D, Al Bogami N, Al Ghamdi K, Al Ghamdi A, Balaraj K, Seyam R, Al Otaibi M, Al Saeed E.

Urol Ann. 2011 Mar;3 Suppl:S10-6. doi: 10.4103/0974-7796.78550. Erratum in: Urol Ann. 2011 May;3(2):61. Rabbah, Dany [corrected to Rabah, Danny].

17.

Saudi Oncology Society clinical management guidelines for renal cell carcinoma.

Bazarbashi S, Al Othman K, Al Otaibi M, Abusamra A, Rabah D, Aljubran A, Murshid E, Al Oraifi I, El-Naghi M, Bahader Y, Soudy H, Rehman A.

Urol Ann. 2011 Mar;3 Suppl:S3-5. doi: 10.4103/0974-7796.78548.

18.

Health related quality of life in ureteral stone patients: post-ureterolithiasis.

Rabah DM, Alomar M, Binsaleh S, Arafa MA.

Urol Res. 2011 Oct;39(5):385-8. doi: 10.1007/s00240-011-0375-9. Epub 2011 Apr 3.

PMID:
21461963
19.

Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians.

Shan J, Al-Rumaihi K, Rabah D, Al-Bozom I, Kizhakayil D, Farhat K, Al-Said S, Kfoury H, Dsouza SP, Rowe J, Khalak HG, Jafri S, Aigha II, Chouchane L.

J Transl Med. 2013 May 13;11:121. doi: 10.1186/1479-5876-11-121.

20.

Priapism associated with pregabalin.

Alsulihem AA, Rabah DM.

Urol Ann. 2014 Oct;6(4):366-8. doi: 10.4103/0974-7796.141012.

Supplemental Content

Support Center